INTRODUCTION
Gilbert's syndrome is characterised by mild unconjugated hyperbilirubinaemia increased by stress or fasting, in the absence of significant haemolysis or liver disease. The differentiation of this benign condition from chronic liver disease can be difficult without liver biopsy. The administration of nicotinic acid intravenously produces a rise in serum unconjugated bilirubin which is greater and more sustained in patients with Gilbert's syndrome than in normal controls, and it has been suggested that nicotinic acid provocation is a useful diagnostic test.' However, evidence that this test differentiates Gilbert's syndrome and liver disease is lacking. We have compared the effects of nicotinic acid provocation on patients with Gilbert's syndrome and with chronic liver disease.
PATIENTS AND METHODS
We studied 15 patients with biopsy -proved chronic liver disease (10 with hepatitis B surface antigen (HBsAg) negative chronic active hepatitis, 3 with alcoholic hepatitis and 2 with cirrhosis), and 20 patients with Gilbert's syndrome which was diagnosed on the following criteria: intermittent or sustained unconjugated hyperbilirubinaemia for more than six months, normal serum liver enzyme activities and no evidence of significant haemolysis (normal haemoglobin concentration, reticulocyte count, serum lactate dehydrogenase, plasma haemoglobin and haptoglobin, and negative Coombs' test). Serum total and direct (conjugated) bilirubin concentrations were assayed using modified Jendrassik-Grof techniques (diazotised sulphanilic acid -based methods) and unconjugated bilirubin concentrations calculated from the difference (normal total and unconjugated bilirubin concentrations < 18 pmol/l).
Informed consent was obtained from all patients and the nicotinic acid test was performed as described.1 After an overnight fast, patients received fifty milligrams of nicotinic acid by slow intravenous injection. Blood samples were taken for total and conjugated serum bilirubin assay at 30 minute intervals over three hours. A positive result has been defined as a rise of greater than 17 pmol/l in unconjugated bilirubin during the test. 2 
RESULTS
The figure shows the rise in unconjugated bilirubin three hours after administration of nicotinic acid for each patient. The mean rise in patients with Gilbert's syndrome was 21-55 ( ± 9-43) pmol/l (range 3-46) compared with 17-3 ( ± 18-9) pmol/l (range 0-77) in those with liver diease: this difference was not statistically significant. 
